Background-We report findings from optical coherence tomography (OCT) of in-stent neoatherosclerosis as a cause of drug-eluting stent (DES) failure. Methods and Results-Optical coherence tomography and grayscale and virtual histology intravascular ultrasound were performed in 50 patients (30 stable, 20 unstable angina) with 50 DES in-stent restenosis lesions and intimal hyperplasia Ͼ50% of stent area. Median follow-up time was 32.2 months. Overall, 26 lesions (52%) had at least 1 OCT-defined in-stent thin-cap fibroatheroma (TCFA)-containing neointima and 29 (58%) had at least 1 in-stent neointimal rupture. Patients presenting with unstable angina showed a thinner fibrous cap (55 m [interquartile range 42 to 105 m] versus 100 m [interquartile range 60 to 205 m], Pϭ0.006) and higher incidence of OCT-defined TCFA-containing neointima (75% versus 37%, Pϭ0.008), intimal rupture (75% versus 47%, Pϭ0.044), thrombi (80% versus 43%, Pϭ0.010), and red thrombi (30% versus 3%, Pϭ0.012) than stable patients. Fibrous cap thickness negatively correlated with follow-up time (rϭϪ0.318, Pϭ0.024). Compared with DES Ͻ20 months after implantation (the best cut-off to predict TCFA-containing neointima), DES Ն20 months after implantation had a higher incidence of TCFA-containing neointima (69% versus 33%, Pϭ0.012) and red thrombi (27% versus 0%, Pϭ0.007). Patients with unstable (versus stable) angina had an increasing number of unstable OCT findings including TCFA-containing neointima, neointima rupture, and thrombus (Pϭ0.027). The rate of agreement between grayscale intravascular ultrasound and OCT for detecting intimal rupture was 50% and for detecting thrombus was 44%. The agreement between virtual histology intravascular ultrasound and OCT for identifying TCFA-containing neointima was 78%. Conclusions-In-stent neoatherosclerosis may be an important mechanism of DES failure, especially late after implantation. (Circulation. 2011;123:2954-2963.)
I n-stent restenosis (ISR) is generally considered to be a stable process, with an early peak in intimal hyperplasia (IH) followed by a quiescent period beginning 1 year after stent implantation. [1] [2] [3] However, recent studies have reported that one third of patients with ISR present with acute coronary syndromes. 4, 5 Furthermore, there is emerging histological and angioscopic evidence of late de novo in-stent neoatherosclerosis. 6 -10 Using virtual histology intravascular ultrasound (VH-IVUS) analysis we recently reported that in-stent percentage necrotic core (%NC) and percentage dense calcium (%DC) increase over time in both bare metal stent and drug-eluting stent (DES)-treated lesions. 11 Most recently, an optical coherence tomography (OCT) study demonstrated that neointima within bare metal stent may transform into lipid-laden atherosclerotic plaque. 12 These studies indicate (1) that in some patients there is degenerative evolution of neointima into an unstable atherosclerotic lesion and (2) that ISR should not always be regarded as a benign entity. The aims of the current study were to report the OCT spectrum of in-stent neoatherosclerosis within DES-treated lesions that presented with ISR and to compare the OCT and grayscale and VH-IVUS findings of in-stent neointimal hyperplasia and in-stent neoathersclerosis.
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Methods Subjects
From February 2007 to November 2010, OCT was performed on 54 consecutive patients with DES restenosis (diameter stenosis Ͼ50% by visual estimation at follow-up angiography). Exclusion criteria were hemodynamic instability, an inability of the OCT imageWire to cross the ISR lesion into the distal vessel because of tight stenosis or severe vessel tortuosity, left main or saphenous vein graft lesions, myocardial infarction, or the presence of angiographically visible thrombus. Optical coherence tomography image analysis was performed at the Asan Medical Center, Seoul, Korea. Because the purpose of study was to characterize neointimal tissue in DEStreated lesions, 1 patient with thrombotic coronary occlusion without significant neointima and 3 ISR patients with dominant-stent underexpansion and little neointima were excluded from the analysis. Finally, 50 patients (30 stable angina and 20 unstable angina) were included in the current study. Virtual histology IVUS were performed in 32 of 50 patients (20 stable and 12 unstable angina) in whom IVUS catheters could cross the ISR lesions after OCT imaging. All patients signed written informed consent before being enrolled in the study.
Angiographic Analysis
Qualitative and quantitative angiographic measurements were performed using standard techniques with automated edge-detection algorithms (CASS-5, Pie-Medical, the Netherlands) in the angiographic analysis center of the Cardiovascular Research Foundation, Seoul, Korea. [13] [14] [15] [16] Angiographic restenosis was defined as a diameter stenosis Ͼ50% at follow-up angiography and classified as suggested by Mehran et al. 13 
Optical Coherence Tomography Imaging and Analysis
The time-domain OCT procedure using the occlusive technique and its anatomic limitations have been previously reported. 17 Optical coherence tomography image acquisition was performed using a commercially available system for intracoronary imaging and a 0.019-inch ImageWire (LightLab Imaging, Westford, MA) before IVUS imaging. The artery was cleared from blood by applying continuous flush delivery as described previously. 18 Flush consisted of iodixanol 370 (Visipaque, GE Health Care, Cork, Ireland) at a flow rate of 3.0 mL/s. Neointima was the tissue between the luminal border and the inner border of the struts. Intimal hyperplasia area was calculated as stent minus intrastent lumen; and % IH was calculated as IH area divided by stent area. Calcific intima was defined as a well-delineated, signal-poor region with sharp borders. Lipidic intima was defined as a signal-poor region with diffuse borders. 19 Thin-cap fibroatheroma (TCFA)-containing intima was defined as fibrous cap thickness at the thinnest part Յ65 m and an angle of lipidic tissue Ն180°. 20 Multiple OCT-defined TCFA-containing neointima were separated by at least 3 mm. Optical coherence tomography neointimal rupture was a break in the fibrous cap that connected the lumen with the underlying lipid pool. 21 Thrombi were masses protruding into the vessel lumen, discontinuous from the surface of the vessel wall and with a dimension Ն250 m. Red thrombi were characterized as high-backscattering protrusions with signal-free shadowing. White thrombi were characterized by signalrich low-backscattering projections into the lumen. 12, [21] [22] [23] When attenuation caused by large amounts of red thrombus obscured underlying neointima morphology, OCT-detectable TCFAcontaining neointima and neointima rupture were identified proximal or distal (or opposite) to the red thrombus.
The axial location of the TCFA-containing intima and/or intimal rupture was assessed (1) at the minimal lumen area site (within 5 mm from the minimal lumen area frame), (2) proximal to the minimal lumen area site, or (3) distal to the minimal lumen area site. The maximal area of each thrombus was measured, and the length of the in-stent segment involved with thrombi was semiquantified as Ͻ25%, 25% to 75%, or Ͼ75% of total stent length.
A microvessel (evidence of neovascularization) was defined as a small vesicular or tubular structure with a diameter Յ200 m. 24 Intraintimal neovascularization was located within the most superficial 50% of the neointimal thickness, and peristent neovascularization was located within the deepest 50% of the neointimal thickness. 12 Stent strut coverage was assessed as previously described. 23 All reported OCT parameters required the agreement of 3 observers (S.J.K., G.S.M., and T.A.) who were blinded to the clinical and procedural characteristics. Examples are shown in Figure 1 .
Intravascular Ultrasound Imaging and Analysis
Intravascular ultrasound imaging was performed after OCT image acquisition and after intracoronary administration of 0.2 mg nitroglycerin using motorized transducer pullback (0.5 mm/s) and a commercial scanner (Boston Scientific/SCIMED, Minneapolis, MN) consisting of a rotating 40MHz transducer within a 3.2Fr imaging sheath. Quantitative volumetric IVUS analysis was performed as previously described. 25, 26 Using computerized planimetry (EchoPlaque 3.0, Indec Systems, Mountain View, CA), stent and reference segments were assessed. Measurements included external elastic membrane (EEM), stent, lumen (intrastent lumen bounded by the borders of the stent and/or IH), and IH (IH ϭstent minus intrastent lumen) areas. Percentage IH was defined as IH area divided by stent area. Stent underexpansion was defined as minimal stent area Ͻ5 mm 2 . 27, 28 Significant IH was defined as % IH area Ͼ50%. Intravascular ultrasound neointimal rupture was identified by the presence of an intra-IH cavity that communicated with the lumen with an overlying residual fibrous cap fragment.
Virtual Histology Intravascular Ultrasound Analysis
Virtual histology IVUS was performed after OCT and grayscale IVUS studies after intracoronary administration of 0.2 mg nitroglycerin using the 2.9Fr Eagle Eye, (Volcano Corp, Rancho Cordova, CA) IVUS catheter that incorporated a 20-MHz electronic-array transducer. The transducer was advanced into the distal reference segment, and an imaging run was performed back through the stent to the proximal reference segments using the R-100 motorized transducer pullback device (0.5 mm/s). By use of pcVH software (Volcano Corp), the region of interest was placed between the luminal border and the inner border of the struts to avoid stent strut artifacts. Virtual histology IVUS analysis coded tissue as green (fibrotic), yellow-green (fibrofatty), white (DC), and red (NC). 29, 30 Neointima tissue component was represented as percentages of measured IH (%fibrous, %fibrofatty, %NC, and %DC). In parallel with the criteria of native VH-TCFA, a VH-defined TCFAcontaining neointima was a lesion fulfilling the following criteria: confluent NC Ͼ10% of in-stent neointima and no evidence of an overlying fibrous cap in at least 3 frames, as previously described by Rodriguez-Granillo et al. 30 Multiple VH-defined TCFA-containing neointima were considered if they were separated by Ն3 consecutive non-TCFA-containing image slices.
Statistical Analysis
All statistical analyses were performed using SPSS (version 10.0, SPSS Inc, Chicago, IL). All values are expressed as the median (interquartile range [IQR]) or as counts and percentages (categorical variables). Continuous variables were compared by use of the nonparametric Mann-Whitney test; categorical variables were compared with 2 statistics or the Fisher exact test. Receiver operating curve was analyzed to assess the best cut-off values of follow-up time predicting TCFA-containing intima with a maximal accuracy using MedCalc (MedCalc Software, Mariakerke, Belgium). A P value Ͻ0.05 was considered statistically significant.
Results
Baseline Clinical and Procedural Characteristics
The clinical and procedural characteristics of the 50 ISR patients are summarized in Table 1 
Angiographic and Intravascular Ultrasound Findings
Quantitative angiographic and grayscale IVUS data are presented in Table 2 . At the minimal lumen area (MLA) site using IVUS, 8 stents (16%) were underexpanded. Also using IVUS, in-stent neointimal rupture was detected in 10 lesions (20%), and thrombi were detected in 8 lesions (16%). Pϭ0.040). In 4 lesions with angiographic stent fracture, only 1 lesion showed all 3 OCT findings (intimal rupture, TCFAcontaining neointima, and thrombi) whereas the remaining 3 lesions had none of these findings.
Optical Coherence Tomography Findings According to Clinical Presentation
In Table 3 , OCT characteristics are compared in patients with unstable angina versus stable angina. Overall, 90% of lesions had in-stent lipid-containing neointima. Compared with the stable angina group, the unstable angina group had a thinner fibrous cap (Pϭ0.006) and a higher incidence of TCFAcontaining neointima (Pϭ0.008) and intimal rupture (Pϭ0.044). The number of neoatherosclerotic OCT findings was greater in patients with an unstable angina presentation than in those with a stable presentation (Pϭ0.027). Thrombi were identified in 29 patients (58%). The length of thrombi was shorter than 25% of total stent length in 25 of the thrombi-containing lesions (86%). Thrombi were more common in patients with unstable angina (80% versus 43%, Pϭ0.010) than in those with stable angina. In addition, red thrombi were also more common in patients with unstable angina (30% versus 3%, Pϭ0.012).
Optical Coherence Tomography Findings According to Follow-Up Duration
Overall, the 26 lesions with a TCFA-containing neointima presented later than the 24 lesions without a TCFAcontaining neointima: 42.3 months (IQR 16.0 to 63.0) versus 11.6 months (IQR 8.0 to 47.4) (Pϭ0.020). Using receiveroperating curve analysis, 20 months was the best predictor of the presence of a TCFA-containing neointima with a sensitivity of 73% and a specificity of 67% (area under curve ϭ0.692, 95% confidence interval ϭ0.546 to 0.815, Pϭ0.001). In Table 4 , OCT characteristics are analyzed using this cut-off value. Comparing ISR patients who presented within 20 months post-stent implantation to those who presented after 20 months, the fibrous cap was thinner, and the incidence of TCFA-containing neointima and multiple TCFA-containing neointima was greater, but the frequency of intimal ruptures and thrombi was similar. There was also a trend that unstable angina presentation was more frequent in patients who presented after 20 months compared to patients who presented within 20 months post-stent implantation (50% versus 29%, Pϭ0.112).
In Figure 2 , we compared patients who presented Ͻ12 months, 12 to 36 months, and Ͼ36 months after stent implantation. Thin-cap fibroatheroma-containing neointima (29% versus 50% versus 68%, Pϭ0.016) and multiple TCFA-containing neointima (0% versus 0% versus 24%, Pϭ0.012) were more common in patients who presented after 36 months than in those who presented earlier. Although the incidence of thrombi was not different among the 3 groups (53% versus 50% versus 64%, Pϭ0.684), red thrombi (0% versus 0% versus 28%, Pϭ0.017) were more frequent in patients who presented after 24 months than in those who presented earlier. Finally, OCT-measured fibrous cap thickness negatively correlated with time to presentation (rϭϪ0.318, Pϭ0.024).
Virtual Histology Intravascular Ultrasound Findings
The Pϭ0.040). Figure 3 shows the frequency of VH-defined TCFA-containing neointima according to follow-up duration. Virtual histology-defined TCFA-containing neointima was seen in 10 lesions (31%). The 10 lesions with a TCFA-containing neointima presented later than the 22 lesions without a TCFA-containing neointima: 49.2 months (IQR 15.9 to 66.8) versus 11.6 months (IQR 7.7 to 41.6), (Pϭ0.006). Also, there was a positive correlation between follow-up time and %DC at the maximal %NC site (rϭ0.510, Pϭ0.015).
Comparison Among Optical Coherence Tomography, Grayscale, and Virtual Histology Intravascular Ultrasound Findings
The clinical and procedural characteristics of the 32 DES-ISR patients who had imaging using all 3 modalities (grayscale, VH-IVUS, and OCT) are described in online-only Data Supplement Table I . The angiographic, IVUS, VH-IVUS, and OCT findings are summarized in the online-only Data Supplement Tables II through IV. Table 5 compares (1) identification of neointimal rupture by both grayscale IVUS and OCT, (2) identification of TCFA-containing neointima by both VH and OCT, and (3) detection of thrombi by both grayscale IVUS and OCT in the subgroup of patients who had imaging using all 3 modalities. The rate of agreement between grayscale IVUS and OCT for detecting intimal rupture was 50% and for detecting thrombus was 44%. The agreement between VH-IVUS and OCT for identifying TCFA-containing neointima was 78%. Using OCT as the gold standard, the sensitivity and specificity of VH-defined TCFA-containing neointima was 60% and 94%, respectively, with positive and negative predictive values of 90% and 73%, respectively. 
Revascularization
All but 1 patient underwent target lesion revascularization (repeat percutaneous coronary intervention [PCI] in 48 patients and coronary artery bypass surgery in 2 patients). Pre-PCI Thrombolysis In Myocardial Infarction (TIMI) 3 flow was observed in 37 lesions (78%). Compared with lesions with TIMI 3 flow, the 13 lesions with TIMI Ͻ3 flow more frequently showed TCFA-containing neointima (85% versus 41%, Pϭ0.007) and intimal rupture (85% versus 48%, Pϭ0.024). In addition, the fibrous cap was thicker in the lesions with TIMI Ͻ3 flow (50 m [IQR 50 to 60] versus 90 m [IQR 60 to 190], Pϭ0.016). The peak post-PCI creatine-kinase MB (CK-MB) showed subtle but significant 
Discussion
In the current study, OCT findings indicating in-stent neoatherosclerosis were frequently identified in patients with DES-ISR, especially late DES-ISR, including TCFA-containing intima in 52%, intimal rupture in 58%, and thrombi in 58%. Irrespective of clinical presentations of DES-ISR (unstable or stable angina), 90% of the lesions had lipid-containing neointima. Even in stable angina patients, one third showed TCFA-containing intima and half had in-stent intimal rupture. Neointimal fibrous cap thickness decreased over time, with a follow-up duration Ͼ20 months being the best cut-off value to predict the presence of TCFA-containing intima. All of these findings suggest either atherosclerotic neointimal degenerative changes over time or neoatherosclerosis superimposed on a stable neointimal platform, consistent with our recent data using VH-IVUS analysis. 11 Furthermore, VH subgroup analysis in the current study supported OCT findings in that the presence of VH-defined TCFA-containing neointima and high content of NC was related to the longer follow-up duration. Although Gonzalo et al previously reported various OCT patterns of restenotic tissue after stenting (84% were various DES), the median follow-up time was only 12 months, too short to manifest the entire spectrum of neoatherosclerosis as suggested in the current study; in the current study, the best predictor of a TCFA-containing neointima was a 20-month follow-up period after DES implantation. 24 Furthermore, the current study showed that patients with late DES-ISR were more likely to have an unstable clinical presentation compared to those with early DES-ISR.
Recently, Takano et al suggested that lipid-laden neointima, neointimal disruption, and thrombus as detected by OCT were more frequently found late (Ն5 years) in comparison with early (Ͻ6 months) after bare metal stent implantation. 12 This was also similar to our observations in DES-treated lesions. However, our findings suggested that the transformation into atheromatous lipid-laden tissue occurred earlier after DES implantation than after bare metal stent implantation, consistent with the angioscopic findings of Higo et al 10 and the histological findings of Nakazawa et al. 31, 32 Although thrombi were observed in 43% of stable angina ISR patients, most were white thrombi that were of relatively small size. In the current study, the presence of thrombi, especially red thrombi, was associated with unstable angina.
The higher incidence of in-stent TCFA-containing neointima, thrombi, and neointimal rupture in unstable angina patients supported the concept that these OCT findings were similar to vulnerable plaque in a native coronary artery. Our previous VH-IVUS study suggested that neoatherosclerosis with a large necrotic core can develop within previously placed stents. 11 Furthermore, in the current study, TIMI flow at presentation was reduced in lesions showing neointimal rupture or TCFA-containing neointima, and preprocedural OCT findings of neointimal rupture significantly correlated with the peak level of post-PCI CK-MB similar to percutaneous revascularization in unstable native artery lesions. Mostly using IVUS, we previously reported in-stent neointimal rupture as a cause of very late stent thrombosis. 33 In this previous study, disease progression with in-stent neointimal rupture was observed in 43.5% of DES lesions and 100% of bare metal stent lesions, suggesting that rupture of in-stent neoatherosclerosis was an important mechanism of very late stent thrombosis. With the excellent resolution of OCT, the current study clarified that many ISR lesions developed neoatherosclerotic changes within the neointima, especially late after implantation. However, it was not clear why some in-stent neoatherosclerosis culminated in acute coronary syndrome and some did not. Furthermore, the current data did not indicate whether all DES-treated lesions would eventually develop in-stent neoatherosclerosis or only some lesions and why.
Owing to the greater spatial resolution of OCT, the incidences of OCT-detected neointimal rupture and thrombi were higher compared with grayscale IVUS. This is similar to the observations of de novo atherosclerotic plaque rupture (73% versus 40%) and thrombi (100% versus 33%) assessed by OCT versus grayscale IVUS in patients with acute myocardial infarction. 34 As in native coronary arteries, these OCT findings suggest that atherosclerotic degeneration of the neointima with development of a TCFA-containing neointima may lead to neointimal rupture and stent thrombosis, as shown previously. 33 Using OCT as the gold standard, grayscale IVUS poorly predicted OCT-defined neointimal rupture, with a sensitivity of 16%, a specificity of 100%, a positive predictive value of 100%, and negative predictive value of 45%. Additionally, grayscale IVUS predicted OCT-defined thrombi with a sensitivity of 15% and a specificity of 92%.
In the current study, the agreement of VH-IVUS and OCT-defined TCFA-containing intima was 78%. Sawada et al previously reported the discrepancy in the frequency of TCFA detected by VH-IVUS and OCT in native plaques. 35 Although OCT has the potential to visualize the thin fibrous cap and evaluate detailed structures, large calcified lesions may be misdiagnosed as TCFA because of low signal penetration of OCT. Conversely, mural thrombi or superficial dense calcium might obscure the presence of VH-defined TCFA-containing intima. Nevertheless, the OCT and VH-IVUS findings in the current analysis seemed to be linked in that VH %NC was much greater in lesions with OCT-defined TCFA-containing intima and OCT-measured fibrous cap was thinner in lesions with VH-IVUS-defined TCFA-containing intima.
Finally, recent clinical studies have suggested that there may be a late catch-up phenomenon in some patients after DES implantation. 36 The current findings suggest that the mechanism of late catch-up may be in-stent neoatherosclerosis and not just progressive IH.
Limitations
First, the present study is not a true study of the natural history of stented lesions in which the same stents are serially studied at different time periods after implantation. Second, the sample size was relatively small, and all patients were symptomatic and presented relatively late because of DES failure. Therefore, we cannot comment on the frequency of these findings in unselected patients after DES placement, especially patients who present with earlier DES failure. Third, we could not demonstrate the impact of these OCT findings on long-term clinical events. Fourth, patients with angiographically visible thrombi with high embolic risk and hemodynamic instability were excluded from OCT imaging. There are differences in drug, release kinetics, and polymers among the different DES. We studied only ISR lesions in which IH was the dominant mechanism of restenosis, excluding stented lesions showing underexpansion with little neointima. Therefore, the current findings cannot be applied to the population with acute myocardial infarction and stent thrombosis or to all types of DES. Fifth, attenuation caused by large amounts of red thrombus obscured underlying neointima morphology; OCT-defined TCFA-containing neointima and neointima rupture were typically seen proximal or distal (or opposite) to the red thrombus and not behind the thrombus, which might have lead to an underestimation of the presence of TCFA-containing neointima and neointimal ruptures. Sixth, the incidence of VH-defined TCFA-containing intima and %NC might be underestimated in lesions with mural thrombi. Seventh, even though VH-IVUS has been applied to clinical research, the accuracy of necrotic core detection using VH-IVUS versus real histology has been debatable among studies of human and porcine coronary lesions. 29, 37 Moreover, VH-IVUS characterization of neointima has never been validated. With the lack of histological confirmation, future pathological studies are necessary to validate these OCT and particularly these VH-IVUS findings. Eighth, we cannot exclude the possibility that the OCT procedure may have contributed to some of the findings such as neointimal rupture; however, patients who required predilation before the OCT imaging were systematically excluded. Finally, many of the OCT neointimal ruptures and thrombi were small, especially in stable patients, and were evidence of in-stent neoatherosclerosis causing ISR and were not responsible for clinical instability.
Conclusion
The current OCT findings demonstrate in-stent TCFAcontaining neointima, neointimal rupture, and thrombi in DES failure patients presenting with ISR (whether stable or unstable). These findings suggest that in-stent neoatherosclerosis assessed by OCT and VH-IVUS may be an important mechanism of DES failure, especially late after implantation.
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